Protein S deficiency

Protein S deficiency is a rare but potentially serious disorder associated with an increased risk of thrombotic events. Protein S is a plasma glycoprotein that plays a key role in maintaining hemostasis by promoting the breakdown of prothrombin and inhibiting the activity of coagulation factors such as factor V and factor VIII. Protein S deficiency can be either hereditary or acquired, which affects its clinical presentation and treatment approaches. Clinical manifestations include recurrent venous thromboembolism and the risk of thrombotic events, particularly in the deep veins. There is also evidence that the risk of venous thromboembolism is increased during pregnancy and after surgery.

History of the disease and interesting historical facts

Protein S deficiency was first described in 1978 when W. F. Pugh and colleagues noted its role in hemorrhagic conditions. Since then, many studies have been conducted to identify the genetic basis of the disorder and its clinical aspects. The disorder has been recognized as significant among inherited hemostatic disorders, which has led to intensive research in the field of thrombophilia. Interestingly, protein S deficiency can occur in patients with normal levels of other anticoagulants, making diagnosis difficult.

Epidemiology

Protein S deficiency has an incidence of 1 in 500 to 1 in 2500 individuals, depending on the ethnic group. Hereditary protein S deficiency is more common in people of European descent, while African and Asian populations have lower incidences. Population studies have confirmed that individuals with hereditary deficiency have an average 8-10% higher risk of venous thromboembolism than the general population. In addition, women of reproductive age are at particularly high risk due to possible thromboembolism during pregnancy and the postnatal period.

Genetic predisposition to this disease

Protein S deficiency is caused by mutations in the PROS1 gene, located on chromosome 20. Current research has shown that there are several types of mutations that can lead to functional or quantitative protein deficiency. The most common genetic variants include point mutations and deletions. Disturbances in this gene can be autogenous, meaning that both parents must pass on the mutant allele for their offspring to be susceptible to the disease. Establishing a link between genetic background and clinical manifestations remains an urgent task for hemostasis researchers.

Risk factors for the development of this disease

There are several known risk factors that contribute to the development of protein S deficiency-associated thrombophilia:

• Heredity: having relatives with thrombophilia.
• Pregnancy: changes in hormonal levels increase the risk of blood clots.
• Surgery and trauma: Surgery and immobilization increase venous congestion.
• Smoking: increases blood viscosity and reduces the activity of anticoagulants.
• Use of oral contraceptives: may increase the risk of blood clots.

Diagnosis of this disease

The diagnosis of protein S deficiency is based on a combination of clinical presentation and laboratory tests. The main symptoms may include:

• Recurrent venous thromboembolism.
• Deep vein thrombosis (DVT).
• Increased susceptibility to thrombosis at an undeservedly young age.

Laboratory tests play a key role in diagnosis and include:

• Measurement of plasma protein S levels.
• Test for protein C activity and levels of proinflammatory markers.
• Testing for mutations in the PROS1 gene.

Radiological examinations such as vascular ultrasound can help identify thrombi in the veins. Differential diagnosis should include other thrombophilias such as antithrombin III and protein C deficiency.

Treatment

Treatment of protein S deficiency may include both general and specific approaches:

• General treatment: Lifestyle changes, including stopping smoking and weight control.
• Pharmacological treatment: Anticoagulants such as warfarin or newer oral anticoagulants may be used to prevent blood clots.
• Surgical treatment: In rare cases, thrombectomy or placement of cavofilters to prevent blood clots may be required.
• Other treatments include the use of anti-inflammatory and immunosuppressive drugs in cases of autoimmune disorders affecting hemostasis.

List of medications used to treat this disease

The following drugs are currently used in clinical practice:

• warfarin
• Dabigatran
• Rivaroxaban
• Apixaban
• Thrombolytics (for thrombosis)

Disease monitoring

Monitoring the patient's condition includes regular control steps such as:

• Checking the level of anticoagulants in plasma.
• Clinical monitoring of thrombosis symptoms.
• Periodic assessment of renal and hepatic function.

The prognosis depends on prompt diagnosis and treatment. Patients with protein S deficiency are at risk of recurrent thrombosis, especially in the postoperative period or during pregnancy. Complications may include thromboembolic events, which can lead to serious conditions such as pulmonary embolism.

Age-related features of the disease

The disease can manifest itself at any age, but clinically significant thrombus formation is more common in young and middle-aged people. In newborns and children, symptoms may be less pronounced, and cases of thrombus formation are more often associated with surgical interventions or serious infections. In adulthood, the risk of thrombus formation increases, especially in women of reproductive age. In older people, the disease may be combined with comorbid pathology, which complicates diagnosis and treatment.

Questions and Answers

• What is protein S deficiency?
  Protein S deficiency is a disorder in which there is not enough protein S in the body, which will lead to an increased risk of blood clots.
• What are the main symptoms of protein S deficiency?
  The main symptoms include recurrent venous thromboembolism, deep vein thrombosis and an increased susceptibility to thrombosis at a young age.
• What diagnostic methods are used?
  Diagnostic methods include laboratory tests for protein S levels, genetic testing, vascular ultrasound, and clinical examination.
• How is protein S deficiency treated?
  Treatment may include lifestyle changes, anticoagulants, and, in rare cases, surgery.
• What is the prognosis for protein S deficiency?
  The prognosis depends on the timeliness of diagnosis and treatment. With the right approach, the risk of thrombosis can be significantly reduced.